MALVERN, Pa. & MONTREAL--(BUSINESS WIRE)--Gemin X Pharmaceuticals today announced that Dr. Anne Roulston will present at the Cambridge Healthtech Institute’s Molecular Medicine Tri-Conference on March 27, 2008 at 9:30 AM PDT at the Moscone Centre in San Francisco. Dr. Roulston will discuss the approach used to identify the key mechanism-of-action of GMX1778 and the new opportunities this information provides for the clinical development of GMX1777.
